A Phase II randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients (2014-2015)
Experts
Emeritus Professor
Jeffrey Lipman
Emeritus/Emerita/Emeritx Professor
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
